These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27704648)

  • 1. A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease.
    Sood SL; James AH; Ragni MV; Shapiro AD; Witmer C; Vega R; Bolgiano D; Konkle BA
    Haemophilia; 2016 Nov; 22(6):e562-e564. PubMed ID: 27704648
    [No Abstract]   [Full Text] [Related]  

  • 2. A decreased and less sustained response to surrogates of haemostatic stress correlates with bleeding in type 1 von Willebrand disease.
    Kloosterman R; Zago-Schmitt M; Grabell J; Thibeault L; Chaigneau M; Hinds M; Hopman W; Bowman M; Harpell L; Johri AM; Good D; James P
    Haemophilia; 2023 Jan; 29(1):370-373. PubMed ID: 36433930
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory diagnostic approach of the parents-children relationship in differentiating low-level von Willebrand factor from mild type 1 von Willebrand disease.
    Akin M
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):351-3. PubMed ID: 22450546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation.
    Giannini S; Solimando M; Fierro T; Baronciani L; Federici AB; Gresele P
    Thromb Haemost; 2011 May; 105(5):921-4. PubMed ID: 21359411
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of Hemorrhagic Moyamoya Disease Associated with Von Willebrand Disease.
    Suzuki Y; Shiba M; Wada H; Yasuda R; Toma N; Suzuki H
    World Neurosurg; 2019 Oct; 130():335-338. PubMed ID: 31326638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is gingival bleeding a symptom of patients with type 1 von Willebrand disease? A case-control study.
    Weickert L; Miesbach W; Alesci SR; Eickholz P; Nickles K
    J Clin Periodontol; 2014 Aug; 41(8):766-71. PubMed ID: 24814158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low von Willebrand factor: sometimes a risk factor and sometimes a disease.
    Sadler JE
    Hematology Am Soc Hematol Educ Program; 2009; ():106-12. PubMed ID: 20008188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Von Willebrand disease type 1 and pregnancy].
    Scholz U; Oppermann J; Siegemund A; Schobess R
    Hamostaseologie; 2011 Nov; 31 Suppl 1():S11-3. PubMed ID: 22057828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?
    Borghi M; Guglielmini G; Mezzasoma AM; Falcinelli E; Bury L; Malvestiti M; Gresele P
    Haematologica; 2017 Nov; 102(11):e431-e433. PubMed ID: 28751564
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
    Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
    J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand disease and aging: an evolving phenotype.
    Sanders YV; Giezenaar MA; Laros-van Gorkom BA; Meijer K; van der Bom JG; Cnossen MH; Nijziel MR; Ypma PF; Fijnvandraat K; Eikenboom J; Mauser-Bunschoten EP; Leebeek FW;
    J Thromb Haemost; 2014 Jul; 12(7):1066-75. PubMed ID: 24750783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Tranexamic Acid for the Treatment of Mittelschmerz in a Patient with Type 1 von Willebrand Disease and Recurrent Hemorrhagic Cysts.
    Lasry A; Gil Y; Balayla J
    J Obstet Gynaecol Can; 2020 Nov; 42(11):1385-1387. PubMed ID: 32482469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.